309. Multidrug-Resistant Organism Colonisation and Surgical Site Infections Following Liver Transplantation

Abstract Background Liver transplant (LTx) recipients are at increased risk of surgical site infections (SSIs). We explored potential risk factors for SSIs post-LTx including colonisation with multidrug-resistant organisms (MDRO) and aimed to assess the impact of perioperative antibiotics targeted at colonising MDRO on the subsequent risk of SSI. Methods A retrospective analysis of adults undergoing LTx at a tertiary referral centre between 2015–2022 was conducted. MDRO colonisation status was determined by routine rectal screening for MDRO including vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing (ESBL) and carbapenemase-producing Enterobacterales (CPE) at time of LTx. The primary outcome was SSI defined using CDC/NHSN criteria. Clinical features related to the patient and donor organ were retrieved from medical records. A multivariable analysis was conducted to evaluate the impact of MDRO colonisation and targeted antibiotics on 30-day SSI risk. Results Of 462 patients who underwent LTx, 157/462 (34.0%) were colonised with MDRO (131 [28.4%] VRE and 38 [8.4%] ESBL/AmpC/CPE). The 30-day SSI rate was 11.9% (55/462), including 16.4% superficial, 5.2% deep incisional and 78.4% organ-space infections. Post-operative biliary complications (aOR 2.1 95% CI 0.98-4.27; P=0.048) and post-LTx haemodialysis (aOR 3.84; 95% CI 1.75-8.17, P= 6e-04) were significantly associated with increased SSI risk on multivariable analysis. There was no association between MDRO colonisation and risk of SSI following LTx (aOR 1.47; 95% CI 0.79-2.71, P=0.2195)). Among MDRO colonised patients (n=157), the use of perioperative antibiotics targeted at colonising MDRO was not associated with reduced SSI risk (aOR 0.40; 95% CI 0.08-1.4; P=0.189). Conclusion SSIs following LTx most commonly involve deep organ spaces. MDRO colonisation was not independently associated with an increased SSI risk, and receiving directed-perioperative antibiotic prophylaxis did not decrease SSI risk. Disclosures All Authors: No reported disclosures

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-01-01
DOI
https://doi.org/10.1093/ofid/ofaf695.105
Primary Topic
Surgical site infection prevention
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

309. Multidrug-Resistant Organism Colonisation and Surgical Site Infections Following Liver Transplantation

Nirbaanjot Walia, Adam Testro, Olivia Catherine Smibert, Jason A. Trubiano et al.
Open Forum Infectious Diseases
Surgical site infection prevention
article

309. Multidrug-Resistant Organism Colonisation and Surgical Site Infections Following Liver Transplantation

Nirbaanjot Walia, Adam Testro, Olivia Catherine Smibert, Jason A. Trubiano, Katrina Tan, Mohamed Nasra, Graham Starkey, Jason C. Kwong, Marcos Perini, Avik Majumdar, Marie Sinclair
article en

Abstract

Abstract Background Liver transplant (LTx) recipients are at increased risk of surgical site infections (SSIs). We explored potential risk factors for SSIs post-LTx including colonisation with multidrug-resistant organisms (MDRO) and aimed to assess the impact of perioperative antibiotics targeted at colonising MDRO on the subsequent risk of SSI. Methods A retrospective analysis of adults undergoing LTx at a tertiary referral centre between 2015–2022 was conducted. MDRO colonisation status was determined by routine rectal screening for MDRO including vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing (ESBL) and carbapenemase-producing Enterobacterales (CPE) at time of LTx. The primary outcome was SSI defined using CDC/NHSN criteria. Clinical features related to the patient and donor organ were retrieved from medical records. A multivariable analysis was conducted to evaluate the impact of MDRO colonisation and targeted antibiotics on 30-day SSI risk. Results Of 462 patients who underwent LTx, 157/462 (34.0%) were colonised with MDRO (131 [28.4%] VRE and 38 [8.4%] ESBL/AmpC/CPE). The 30-day SSI rate was 11.9% (55/462), including 16.4% superficial, 5.2% deep incisional and 78.4% organ-space infections. Post-operative biliary complications (aOR 2.1 95% CI 0.98-4.27; P=0.048) and post-LTx haemodialysis (aOR 3.84; 95% CI 1.75-8.17, P= 6e-04) were significantly associated with increased SSI risk on multivariable analysis. There was no association between MDRO colonisation and risk of SSI following LTx (aOR 1.47; 95% CI 0.79-2.71, P=0.2195)). Among MDRO colonised patients (n=157), the use of perioperative antibiotics targeted at colonising MDRO was not associated with reduced SSI risk (aOR 0.40; 95% CI 0.08-1.4; P=0.189). Conclusion SSIs following LTx most commonly involve deep organ spaces. MDRO colonisation was not independently associated with an increased SSI risk, and receiving directed-perioperative antibiotic prophylaxis did not decrease SSI risk. Disclosures All Authors: No reported disclosures

Open Forum Infectious DiseasesVol. 13(Supplement_1)
Austin Health (AU)
Openalex Percentile: Top 91%
Surgical site infection prevention
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.